Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Retrospective Analysis
100%
Hospitalization
100%
Antipsychotics
100%
Second-generation Antipsychotics
100%
Medicare Current Beneficiary Survey
100%
Medicare Beneficiaries
40%
Odds Ratio
30%
Hospital Services
20%
Tolerability
10%
Disability Status
10%
Disability
10%
Haloperidol
10%
Cognitive Impairment
10%
Confounding Variables
10%
Health Behavior
10%
Fluphenazine
10%
Chlorpromazine
10%
Atypical Antipsychotics
10%
Socioeconomic
10%
Health Research
10%
Memory Loss
10%
Quetiapine
10%
Daily Activities
10%
Typical Antipsychotics
10%
Smoking Status
10%
Alzheimer's Disease Diagnosis
10%
Conclusive Evidence
10%
All Ages
10%
Final Model
10%
Ziprasidone
10%
Activities of Daily Living
10%
Aripiprazole
10%
Non-institutional
10%
Risperidone
10%
Behavioral Activity
10%
Thioridazine
10%
Hospital Visits
10%
Thiothixene
10%
Patient Use
10%
Loxapine
10%
Crouching
10%
Breslau
10%
Impairments Diagnosis
10%
Kneeling
10%
Body Mass Index Status
10%
Disease Losses
10%
Clozapine Olanzapine
10%
Survey Costs
10%
Perphenazine
10%
All-cause Hospitalization
10%
Psychiatric Readmission
10%
Housework
10%
Limitations in Activities
10%
Trifluoperazine
10%
Neuroscience
Antipsychotic
100%
Behavior (Neuroscience)
33%
Alzheimer's Disease
33%
Cognitive Disorders
33%
Body Mass Index
33%
Chlorpromazine
33%
Atypical Antipsychotic
33%
Quetiapine
33%
Typical Antipsychotic
33%
Clozapine
33%
Fluphenazine
33%
Aripiprazole
33%
Risperidone
33%
Olanzapine
33%
Loxapine
33%
Trifluoperazine
33%
Perphenazine
33%
Thioridazine
33%
Thiothixene
33%
Ziprasidone
33%
Haloperidol
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Alzheimer's Disease
33%
Tolerability
33%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
33%
Cognitive Defect
33%
Typical Antipsychotic
33%
Chlorpromazine
33%
Thiothixene
33%
Fluphenazine
33%
Clozapine
33%
Olanzapine
33%
Atypical Antipsychotics
33%
Quetiapine
33%
Ziprasidone
33%
Aripiprazole
33%
Risperidone
33%
Thioridazine
33%
Loxapine
33%
Trifluoperazine
33%
Perphenazine
33%
Nursing and Health Professions
Medicare
100%
Odds Ratio
50%
Hospital Service
33%
Alzheimer's Disease
16%
Body Mass
16%
Cognitive Defect
16%
Confounding Variable
16%
Hospital Readmission
16%
Atypical Antipsychotics
16%
Clozapine
16%
Typical Antipsychotic
16%
Perphenazine
16%
Thioridazine
16%
Thiothixene
16%
Loxapine
16%
Quetiapine
16%
Ziprasidone
16%
Chlorpromazine
16%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
16%
Olanzapine
16%
Risperidone
16%
Trifluoperazine
16%
Aripiprazole
16%
Fluphenazine
16%
Adherence
16%
Psychology
Medicare
100%
Body Mass Index
16%
Alzheimer's Disease
16%
Cognitive Impairment
16%
Olanzapine
16%
Chlorpromazine
16%
Haloperidol
16%